证券代码：600718 证券简称：东软集团 公告编号：临 2025-018 东软集团股份有限公司 关于注销公司已回购股份的提示性公告 （二）回购实施情况 2024 年 4 月 24 日，公司完成回购，实际通过集中竞价方式回购公司股份 18,225,976 股，占公司目前总股本的 1.5020%，回购成交的最高价为 8.72 元/ 股，回购成交的最低价为 6.41 元/股，回购均价为 7.96 元/股，已支付资金总额 为 145,003,509.53 元人民币（不含印花税、佣金等交易费用），回购方案实际执 行情况与原披露的回购方案不存在差异。具体内容，详见本公司于 2024 年 4 月 25 日刊登在《中国证券报》《上海证券报》上的相关公告。 二、本次注销股份的原因、数量 根据公司回购方案，本次回购股份目的是维护公司价值及股东权益，回购所 得股份将在回购完成之后全部予以注销。为此，公司拟对回购专用账户中的 18,225,976 股股份予以注销。 三、本次注销完成后股权结构变动情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：600718 证券简称：东软集团 公告编号：临 2025-017 东软集团股份有限公司 关于 2024 年股票期权激励计划 第一个行权期行权条件成就的公告 （一）本激励计划方案的主要内容 2024 年股票期权激励计划（以下简称"本激励计划"）第一个行权期可 行权数量：1,120.136 万份； 根据《激励计划》，公司拟向 162 名符合条件的激励对象授予 3,234 万份股 票期权，占本激励计划草案及摘要公告日公司总股本 1,213,413,212 股的 2.67%。 本激励计划为一次性授予，无预留部分。本激励计划授予激励对象股票期权的行 权价格为 8.23 元/股。股票来源为公司向激励对象定向发行的本公司 A 股普通股 股票。 2024 年 5 月 6 日，公司股票期权激励计划授予的登记手续办理完成。公司 实际向 162 名激励对象授予 3,234 万份股票期权。具体内容，详见本公司于 2024 年 5 月 8 日刊登在《中国证券报》《上海证券报》上的 ...

证券代码：600718 证券简称：东软集团 公告编号：临 2025-016 东软集团股份有限公司 关于调整 2024 年股票期权激励计划行权价格 及注销部分股票期权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、2024 年股票期权激励计划（以下简称"本激励计划"）已履行的决策程 序和信息披露情况 （一）历次已履行的决策程序和信息披露情况 于 2024 年 2 月 26 日召开的东软集团股份有限公司（以下简称"公司"）十 届八次董事会审议通过了《关于<东软集团股份有限公司 2024 年股票期权激励计 划（草案）>及其摘要的议案》《关于<东软集团股份有限公司 2024 年股票期权 激励计划考核管理办法>的议案》以及《关于提请公司股东大会授权董事会办理 2024 年股票期权激励计划相关事宜的议案》。具体内容，详见本公司于 2024 年 2 月 28 日刊登在《中国证券报》《上海证券报》上的相关公告。 于 2024 年 2 月 26 日召开的公司十届四次监事会审议通过了《关于<东软集 团股份有限公司 2024 年股票期权 ...

Financial Performance - In 2024, Neusoft achieved a revenue growth of 9.64% year-on-year, with operating cash flow reaching a historical high[6]. - The net profit from main operations increased to 435 million yuan, and the first phase of stock option exercise conditions was successfully met[6]. - Neusoft Group reported a revenue of RMB 10.5 billion for the fiscal year 2024, representing a year-over-year growth of 15%[26]. - The company reported a gross margin of 35% for the fiscal year 2024, an improvement from 32% in the previous year[26]. - The net profit attributable to shareholders for 2024 was CNY 63,047,454, a decrease of 14.70% from CNY 73,912,538 in 2023[34]. - The net cash flow from operating activities for 2024 was CNY 855,430,547, reflecting a 7.16% increase from CNY 798,265,849 in 2023[34]. - The company’s total sales expenses rose by 3.86% to CNY 548,630,463, while management expenses increased by 15.93% to CNY 759,338,541[130]. - The company reported a significant increase in financial expenses, which rose by 247.33% to ¥70,529,439 from ¥20,306,344[120]. - The company achieved operating revenue of 1,155.962 million yuan in 2023, completing 98.30% of the projected amount for 2024[160]. Strategic Initiatives - The company has initiated a strategic transformation focusing on intelligent solutions, leveraging AI and big data technologies[6]. - Neusoft is committed to transforming from a technology provider to a value creator, focusing on new business model innovations driven by data and intelligence[8]. - The company plans to expand its market presence in Southeast Asia, targeting a 20% increase in market share by 2025[26]. - The company is investing heavily in AI technology, with a budget allocation of RMB 1 billion for research and development in the next fiscal year[26]. - The company is focusing on innovation and globalization strategies to improve profitability and core competitiveness[158]. - The company is committed to building a collaborative ecosystem with clients and partners to enhance market capabilities[158]. Product Development and Innovation - The company launched several innovative intelligent solutions, including high-quality development solutions for hospitals and medical data value solutions, which have been applied in benchmark projects[7]. - Neusoft's global vehicle intelligence solution, OneCoreGo®, now covers over 110 countries and regions, serving more than 30 well-known automotive companies[6]. - The introduction of the NeuSAR automotive operating system is anticipated to support over 1 million vehicles by the end of 2024[26]. - The company launched innovative county-level medical community solutions, successfully implemented in Faku County, contributing to significant improvements in local healthcare reform[77]. - The company introduced multiple AI-enabled products in 2024, including intelligent review systems and cloud hospital solutions, enhancing the efficiency of healthcare management[80]. Market Expansion and User Growth - The company has seen an increase in user data, with active users of its digital health platform reaching 5 million, up 25% from the previous year[26]. - Neusoft anticipates a revenue guidance of RMB 12 billion for the fiscal year 2025, indicating a projected growth of 14%[26]. - The company is considering strategic acquisitions to enhance its technology portfolio, with a budget of $100 million allocated for potential deals[182]. - Market expansion plans include entering three new international markets by Q3 2024, targeting a 10% market share in each[182]. Corporate Governance and Shareholder Engagement - The company held 2 shareholder meetings during the reporting period, ensuring the protection of shareholder rights and compliance with regulations[167]. - The board of directors consists of 9 members, including 3 independent directors, with a diverse professional background in IT, investment, management, and finance[168]. - A total of 13 board meetings and 3 independent director meetings were held during the reporting period, demonstrating active governance[168]. - The company disclosed 4 periodic reports and 69 temporary announcements during the reporting period, emphasizing its commitment to transparency[171]. - The company is committed to maintaining independence from its controlling shareholders, ensuring operational autonomy[171]. Social Responsibility and Community Engagement - The company continues to focus on social responsibility initiatives, including participation in environmental protection projects and community support programs[170]. - The company supported skill training for 20 million individuals and provided employment matching services for over 8 million people, significantly improving local employment quality[83]. - The company’s smart healthcare business has served over 200 health commissions and 600 tertiary hospitals across 31 provincial-level administrative regions[74]. Financial Outlook and Projections - The company plans to reach an operating revenue of 12.72 billion yuan in 2025, expecting a growth of 10%[160]. - Operating costs are projected to be 9.64 billion yuan in 2025, also anticipating a 10% increase[160]. - The company provided an optimistic outlook, projecting a revenue growth of 20% for the next quarter, aiming for $1.44 billion[182]. - The company is enhancing its data governance capabilities through the CNDP cloud-native data platform, successfully applied in projects for major state-owned enterprises[106].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,849,804,893, representing a 1.06% increase compared to CNY 1,830,426,473 in the same period last year[2] - The net profit attributable to shareholders of the listed company was a loss of CNY 12,090,412, a decrease of 330.18% from a profit of CNY 5,252,539 in the previous year[2] - The basic and diluted earnings per share were both CNY -0.010, reflecting a decline of 332.28% from CNY 0.004 in the same period last year[2] - The net profit for Q1 2025 was a loss of CNY 14.71 million, compared to a profit of CNY 1.91 million in Q1 2024, indicating a significant downturn[15] - The total comprehensive income for Q1 2025 was CNY 2.04 million, a significant drop from a loss of CNY 20.42 million in Q1 2024[16] - Basic and diluted earnings per share for Q1 2025 were both CNY -0.010, compared to CNY 0.004 in Q1 2024, reflecting a decline in profitability[16] Cash Flow and Liquidity - The net cash flow from operating activities was a negative CNY 539,042,085, compared to a negative CNY 515,678,036 in the previous year[2] - The company's cash and cash equivalents decreased to CNY 2,015,465,916 from CNY 2,790,295,116 at the end of 2024[10] - Cash and cash equivalents at the end of Q1 2025 stood at CNY 1.94 billion, down from CNY 1.99 billion at the end of Q1 2024, indicating a decrease in liquidity[19] - The net cash flow from operating activities for Q1 2025 was a negative CNY 539.04 million, compared to a negative CNY 515.68 million in Q1 2024, showing a worsening cash flow situation[18] - Investment activities generated a net cash outflow of CNY 253.73 million in Q1 2025, contrasting with a net inflow of CNY 426.07 million in Q1 2024, indicating a shift in investment strategy[18] Assets and Liabilities - Total assets at the end of the reporting period were CNY 17,987,487,362, down 2.57% from CNY 18,461,736,241 at the end of the previous year[2] - Total liabilities as of March 31, 2025, were CNY 8,421,793,255, down from CNY 8,926,973,061 at the end of 2024[12] - As of March 31, 2025, total assets were CNY 17,987,487,362, a decrease from CNY 18,461,736,241 at the end of 2024[10] Operating Costs and Expenses - The company reported an increase in operating costs, which significantly impacted the net profit attributable to shareholders[5] - The company reported total operating costs of CNY 1,859,478,004 in Q1 2025, compared to CNY 1,845,326,170 in Q1 2024[14] - The company's management expenses for Q1 2025 were CNY 194,653,403, up from CNY 184,417,276 in Q1 2024[14] - R&D expenses for Q1 2025 were CNY 199.88 million, a decrease from CNY 218.19 million in Q1 2024, representing a decline of approximately 8.5%[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 100,095[7] Business Development - The company signed new AI application contracts in vertical fields totaling CNY 189,000,000, with a year-on-year increase of 54%[9] - In the "AI + healthcare" sector, new AI application contracts amounted to CNY 139,000,000, reflecting a significant year-on-year growth of 211%[9]

东软集团股份有限公司 营业收入扣除情况表的鉴证报告 2024 年度 关于东软集团股份有限公司2024年度 营业收入扣除情况表的鉴证报告 信会师报字[2025]第ZA12521号 东软集团股份有限公司全体股东： 我们审计了东软集团股份有限公司(以下简称"东软集团")2024 年度的财务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债 表、2024 年度合并及母公司利润表、合并及母公司现金流量表、合 并及母公司所有者权益变动表和相关财务报表附注，并于 2025 年 4 月 25 日出具了报告号为信会师报字[2025]第 ZA12518 号的无保留意 见审计报告。 在对上述财务报表执行审计的基础上，我们接受委托，对后附的 东软集团2024年度营业收入扣除情况表（以下简称"营业收入扣除情 况表"）执行了合理保证的鉴证业务。 一、管理层的责任 东软集团管理层的责任是按照《上海证券交易所股票上市规则》 和《上海证券交易所上市公司自律监管指南第2号——业务办理》的 相关规定编制营业收入扣除情况表，确保营业收入扣除情况表真实、 准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的 ...

Financial Performance - The basic earnings per share for 2024 is 0.0500 yuan, a decrease of 16.67% compared to 0.0600 yuan in 2023 [1] - The total revenue for 2024 is 11.56 billion yuan, representing a 9.64% increase from 10.544 billion yuan in 2023 [1] - The net profit for 2024 is 0.63 billion yuan, down 14.86% from 0.74 billion yuan in 2023 [1] - The return on equity for 2024 is 0.66%, a decrease of 16.46% from 0.79% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 43.87471 million shares, accounting for 36.46% of the circulating shares, with an increase of 0.80156 million shares compared to the previous period [1] - The largest shareholder, Dalian Neusoft Holdings Co., Ltd., holds 17,420.24 million shares, representing 14.47% of the total share capital, with no change [2] - The second-largest shareholder, Alpine Electronics (China) Co., Ltd., holds 7,868.35 million shares, accounting for 6.54% of the total share capital, also unchanged [2] Dividend Distribution - The company has announced a dividend distribution plan of 1.5 yuan per share (including tax) [3]

北京市海问律师事务所 关于东软集团股份有限公司 2024 年股票期权激励计划调整股票期权行权价格、注销部分已授予 但尚未行权的股票期权、第一个行权期行权条件成就的 法律意见书 致：东软集团股份有限公司 北京市海问律师事务所（以下简称"本所"）是具有中华人民共和国（以下 简称"中国"）法律执业资格的律师事务所。本所接受东软集团股份有限公司（以 下简称"公司"或"东软集团"）的委托，担任东软集团实施 2024 年股票期权激 励计划（以下简称"本次股权激励计划"）的专项法律顾问，就公司本次股权激 励计划调整股票期权行权价格（以下简称"本次调整"）、注销部分已授予但尚未 行权的股票期权（以下简称"本次注销"）、第一个行权期激励对象行权（以下简 称"本次行权"）相关事宜，出具本法律意见书。 本所根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》（以下简 称"《管理办法》"）等法律、法规和规范性文件以及《东软集团股份有限公司章 程》（以下简称"《公司章程》"）的规定，对东软集团提供的有关文件和本次调整、 本次注销、本次行权的有关事实进 ...

东软集团股份有限公司 非经营性资金占用及其他关联资金 往来情况的专项报告 2024 年度 关于东软集团股份有限公司 非经营性资金占用及其他关联资金往来情况 的专项报告 信会师报字[2025]第 ZA12520 号 东软集团股份有限公司全体股东： 我们审计了东软集团股份有限公司(以下简称"东软集团")2024 年度的财务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债 表、2024 年度合并及母公司利润表、合并及母公司现金流量表、合 并及母公司所有者权益变动表和相关财务报表附注，并于 2025 年 4 月 25 日出具了报告号为信会师报字[2025]第 ZA12518 号的无保留意 见审计报告。 东软集团管理层根据中国证券监督管理委员会《上市公司监管指 引第 8 号——上市公司资金往来、对外担保的监管要求》（证监会公 告〔2022〕26 号）和《上海证券交易所上市公司自律监管指南第 2 号——业务办理》的相关规定编制了后附的 2024 年度非经营性资金 占用及其他关联资金往来情况汇总表（以下简称"汇总表"）。 编制汇总表并确保其真实、准确、完整是东软集团管理层的责任。 我们将汇总表所载信息与我 ...

东软集团股份有限公司 内部控制审计报告 2024 年度 内部控制审计报告 信会师报字[2025]第 ZA12519 号 我们的责任是在实施审计工作的基础上，对财务报告内部控制的 有效性发表审计意见，并对注意到的非财务报告内部控制的重大缺陷 进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。 此外，由于情况的变化可能导致内部控制变得不恰当，或对控制政策 和程序遵循的程度降低，根据内部控制审计结果推测未来内部控制的 有效性具有一定风险。 内部控制审计报告第 1 页 四、财务报告内部控制审计意见 我们认为，东软集团于 2024 年 12 月 31 日按照《企业内部控制 基本规范》和相关规定在所有重大方面保持了有效的财务报告内部控 制。 东软集团股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求，我们审计了东软集团股份有限公司（以下简称东软集团）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的规定，建立健全和有效实 ...